Trials / Completed
CompletedNCT02306824
Berlin Atrial Fibrillation Registry
Berlin Cohort Study on Oral Anticoagulation in Patients With Atrial Fibrillation and Acute Ischemic Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,080 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigator-initiated prospective multicentre hospital-based registry to uncover the proportion of self-reported anticoagulation in stroke patients with atrial fibrillation and assessing the proportion of stroke, intracranial bleeding and all-cause death in the short (at 3 months), mid-term (at 12 months) as well as long term (at 24 months) after ischemic stroke or transient ischemic attack in an unselected urban population in Germany. In addition, annual follow-up is planned yearly up to 5 years after enrollment.
Conditions
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2017-11-01
- Completion
- 2020-11-01
- First posted
- 2014-12-03
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02306824. Inclusion in this directory is not an endorsement.